BREST CANCER

Clinical trials for BREST CANCER explained in plain language.

Never miss a new study

Get alerted when new BREST CANCER trials appear

Sign up with your email to follow new studies for BREST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for Tough-to-Treat breast cancer: testing a Triple-Drug attack

Disease control Not yet recruiting

This study is testing a new combination of three drugs (neratinib, fulvestrant, and eribulin) for people with a specific type of advanced breast cancer. It is for patients whose cancer has continued to grow despite treatment with a common drug called trastuzumab deruxtecan. The g…

Matched conditions: BREST CANCER

Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

BREST CANCER

Get alerted when new BREST CANCER trials appear

New hope for Tough-to-Treat breast cancer: testing a Triple-Drug attack